Video

Dr. Leslie on the Encouraging Evolving Treatment Landscape in MCL

Lori A. Leslie, MD, discusses the encouraging evolving treatment landscape in mantle cell lymphoma.

Lori A. Leslie, MD, lymphoma attending, John Theurer Cancer Center, discusses the encouraging evolving treatment landscape in mantle cell lymphoma (MCL). 

It is important to note that past studies in MCL may be outdated as the field is exploding with new information, says Leslie. Prior data painted a more dismal outlook for patients with MCL that may no longer hold true given the current treatment landscape, Leslie adds. 

In recent years, many treatment advances have been implemented ​and will likely contribute to improved patient care in the future, Leslie concludes.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
(CME Track) Clinical Consultations™: Framing a New Approach to Geographic Atrophy Management – Expert Insights into Recent Developments
Video

(CME Track) Clinical Consultations™: Framing a New Approach to Geographic Atrophy Management – Expert Insights into Recent Developments

Apr 23rd 2025 - Apr 24th 2026

online-activity
Optimizing Today and Looking to Tomorrow in Metastatic CRPC—Homing in on EZH2
Video

Optimizing Today and Looking to Tomorrow in Metastatic CRPC—Homing in on EZH2

Apr 23rd 2025 - Apr 24th 2026

online-activity
Addressing Unmet Needs in HER2+ Metastatic BTC
Video

Addressing Unmet Needs in HER2+ Metastatic BTC

Apr 18th 2025 - Apr 19th 2026

online-activity